Orbis Allan Gray LTD has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $15.3 Billion distributed in 127 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Elevance Health, Inc. with a value of $1.11B, Alnylam Pharmaceuticals, Inc. with a value of $692M, British American Tobacco P.L.C. with a value of $686M, Kinder Morgan, Inc. with a value of $665M, and Gxo Logistics, Inc. with a value of $642M.

Examining the 13F form we can see an increase of $1.36B in the current position value, from $13.9B to 15.3B.

Orbis Allan Gray LTD is based out at Hamilton, D0

Below you can find more details about Orbis Allan Gray LTD portfolio as well as his latest detailed transactions.

Portfolio value $15.3 Billion
Healthcare: $3.35 Billion
Financial Services: $2.27 Billion
Industrials: $1.44 Billion
Communication Services: $1.36 Billion
Energy: $1.28 Billion
Technology: $1.19 Billion
Consumer Cyclical: $1.16 Billion
Basic Materials: $1.07 Billion
Other: $1.65 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 127
  • Current Value $15.3 Billion
  • Prior Value $13.9 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 40 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Orbis Allan Gray LTD Portfolio

Follow Orbis Allan Gray LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

News

Stay updated on Orbis Allan Gray LTD with notifications on news.